This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts, particularly at the National Institutes of Health (NIH) and the FDA. This contract award is part of Olink's broader work with federal agencies, including a $3,409,622.12 Indefinite Delivery Contract with the Defense Health Agency to supply reagent kits to the Walter Reed Army Institute of Research's Medical Readiness Systems Biology Branch.
Generated 12/10/24, 2:12 PM